Quoting from BOCX's press release:
"One of the reasons we had such an impact is that each slide showing our own results was followed by a slide showing similar results from a continuing blind test(1) study in collaboration with an independent and highly regarded scientific European group. During the congress we met with the principal investigator of that group and discussed the results obtained so far and the anticipated future work."
My question is how similar were the results from the independent European group? Were they the same as, better than, or worse than BOCX's results? Reading between the lines, the results from the European group were probably somewhat worse than BOCX's (otherwise the press release would have used words like 'identical' or 'almost identical', instead of 'similar'). I also recall a press release some time ago from BOCX about the results obtained by a Japanese group that used histo-RECAF. The Japanese results were also somewhat worse than what BOCX had reported achieving in its own lab. So, the $64k question is:
Is BOCX reporting unduly optimistic results that cannot be duplicated by other groups, or do the other groups simply need more training to achieve the results that BOCX has reported in its own lab?
Does anyone know of a way to get a copy of the BOCX presentation at the conference?
Thanks,
A1
